Avanos Medical (AVNS) FCF Margin Growth (1y) (2014 - 2026)
Avanos Medical (AVNS) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 2,811.00 |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -2,045.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,045.00 |
| Dec 31, 2025 | -800.00 |
| Sep 30, 2025 | -780.00 |
| Jun 30, 2025 | -1,515.00 |
| Mar 31, 2025 | 1,863.00 |
| Dec 31, 2024 | 3,243.00 |
| Sep 30, 2024 | -297.00 |
| Jun 30, 2024 | 1,665.00 |
| Mar 31, 2024 | -51.00 |
| Dec 31, 2023 | -2,042.00 |
| Sep 30, 2023 | 130.00 |
| Jun 30, 2023 | -1,730.00 |
| Mar 31, 2023 | -516.00 |
| Dec 31, 2022 | -10,806.00 |
| Sep 30, 2022 | 341.00 |
| Jun 30, 2022 | 830.00 |
| Mar 31, 2022 | 336.00 |
| Dec 31, 2021 | 13,456.00 |
| Sep 30, 2021 | 1,102.00 |
| Jun 30, 2021 | 864.00 |